Table 2. Cluster membership profiles: age, gender, ethnicity, place of admission, comorbidities, charlson comorbidity index and clinical frailty score. Cluster membership profiles are of the four emergent clusters from a two-step cluster analysis which was carried out clustering hospitalised COVID19 positive patients by: completed hospitalised episode outcomes and BHS deprivation score.
| All patients | Cluster 1 (Highest BHS deprivation regions and died) | Cluster 2 (All other BHS deprivation regions and died) | Cluster 3 (Highest BHS deprivation regions and discharged) | Cluster 4 (All other BHS deprivation regions and discharged) | |
|---|---|---|---|---|---|
| n | 344 | 41 | 64 | 118 | 121 |
| Age (Mean (SD) ) | 67.2 (18.4) | 69.9 (14.3) | 79.8 (12.0) | 59.3 (17.2) | 67.5 (15.0) |
| Gender (n (% within column)) | |||||
| Male | 202 (58.7) | 25 (61.0) | 39 (60.9) | 74 (61.2) | 64 (54.2) |
| Female | 142 (41.3) | 16 (39.0) | 25 (39.1) | 47 (38.8) | 54 (45.8) |
| Ethnicity (n (% within column)) | |||||
| BAME | 113 (32.8) | 19 (48.7) | 14 (22.2) | 47 (40.2) | 33 (28.2) |
| Caucasian | 223 (64.8) | 20 (51.3) | 49 (77.8) | 70 (59.8) | 84 (71.8) |
| Place of Admission (n (% within column)) | |||||
| Nursing/Residential home | 47 (13.7) | 9 (22.0) | 20 (31.3) | 5 (4.2) | 13 (10.7) |
| Private residence | 297 (86.3) | 32 (78.0) | 44 (68.8) | 116 (98.3) | 105 (86.8) |
| Comorbidities (n (% within column)) | |||||
| Chronic Kidney disease | 103 (29.9) | 14 (34.1a,b) | 32 (50.0a) | 20 (16.5b) | 37 (31.4) |
| Dementia | 32 (9.3) | 9 (22.0a,b) | 9 (14.1a) | 5 (4.1b) | 9 (7.6) |
| Ischaemic Heart disease | 69 (20.1) | 12 (30.0a,b) | 19 (29.7a) | 16 (13.2b) | 22 (18.8) |
| Hypertension | 164 (47.7) | 21 (52.5a,b) | 40 (62.5a) | 51 (42.9) | 52 (44.8) |
| Type 2 Diabetes Mellitus | 116 (33.7) | 16 (39.0a,b) | 26 (40.6a) | 39 (32.2) | 35 (29.7) |
| Charlson comorbidity index (median (IQR)) | 4.00 (4.00) | 6 (5.00) | 6 (3.00) | 2 (4.00) | 4 (4.00) |
| Clinical frailty score (median (IQR)) | 4.00 (4.00) | 6 (4.00) | 6 (3.00) | 3 (3.00) | 4 (4.00) |
a
Note: Among patients who died, there is no statistical significance in the respective comorbidity profiles between patients admitted from regions of highest BHS deprivation and all other BHS deprivation regions
b
Among patients admitted from regions of highest BHS deprivation, there is a statistical significance in the respective comorbidity profiles between patients who died and those who were discharged.